Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06607562

Effectiveness and Safety of Probiotics in Protecting Liver Function

Protective Effect of Probiotics BC99 on Liver Function in Long-Term Alcohol Consumers: A Randomized, Double-Blind, Placebo-Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Wecare Probiotics Co., Ltd. · Industry
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Accepted

Summary

To evaluate the effectiveness and safety of using probiotics to protect the liver function of long-term alcohol consumers

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic groupThe experimental phase of this study lasted for 56 days, during which we will measure participants' liver function, such as alanine aminotransferase (ALT) at baseline and end.
DIETARY_SUPPLEMENTPlacebo groupThe experimental phase of this study lasted for 56 days, during which we will measure participants' liver function, such as alanine aminotransferase (ALT) at baseline and end.

Timeline

Start date
2024-06-03
Primary completion
2024-12-15
Completion
2025-04-15
First posted
2024-09-23
Last updated
2024-09-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06607562. Inclusion in this directory is not an endorsement.

Effectiveness and Safety of Probiotics in Protecting Liver Function (NCT06607562) · Clinical Trials Directory